Mental symptoms in Huntington's disease and a possible primary aminergic neuron lesion.
Monoamine oxidase activity was higher in the cerebral cortex and basal ganglia of patients dying from Huntington's disease than in controls. Enzyme kinetics and multiple substrate studies indicated that the increased activity was due to elevated concentrations of monoamine oxidase type B. Concentrations of homovanillic acid were increased in the cerebral cortex but not in the basal ganglia of brains of patients with Huntington's disease. These changes may represent a primary aminergic lesion that could underlie some of the mental symptoms of this disease.
D001479:Basal Ganglia / Q000201:enzymology*; D002540:Cerebral Cortex / Q000201:enzymology*; D004298:Dopamine / Q000502:physiology; D005260:Female; D006719:Homovanillic Acid / Q000378:metabolism*; D006801:Humans; D006816:Huntington Disease / Q000150:complications / Q000503:physiopathology*; D008297:Male; D008995:Monoamine Oxidase / Q000378:metabolism*; D010648:Phenylacetates / Q000378:metabolism*; D011618:Psychotic Disorders / Q000209:etiology / Q000503:physiopathology; D013379:Substrate Specificity
D010648:Phenylacetates; D008995:Monoamine Oxidase; D004298:Dopamine; D006719:Homovanillic Acid